Limited agreement between biomarkers of neuronal injury at different stages of Alzheimer's disease

Alzheimer's and Dementia

Volumn 10, Issue 6, 2014, Pages 684-689

  Alexopoulos, Panagiotis ^a,b   Kriett, Laura ^a   Haller, Bernhard ^c   Klupp, Elisabeth ^a   Gray, Katherine ^d   Grimmer, Timo ^a   Laskaris, Nikolaos ^e   Förster, Stefan ^a   Perneczky, Robert ^a,d,f   Kurz, Alexander ^a   Drzezga, Alexander ^g   Fellgiebel, Andreas ^h   Yakushev, Igor ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF PATRAS   (Greece)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^f WEST LONDON MENTAL HEALTH NHS TRUST   (United Kingdom)

^g UNIVERSITY OF COLOGNE   (Germany)

^h UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Agreement; Dementia; Diagnostic criteria; FDG PET; Hippocampal atrophy; Tau

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4; BIOLOGICAL MARKER; FLUORODEOXYGLUCOSE F 18; GLUCOSE; TAU PROTEIN; APOLIPOPROTEIN E;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN SIZE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GLUCOSE METABOLISM; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NERVE CELL LESION; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; ATROPHY; CHI SQUARE DISTRIBUTION; COMPLICATION; DIAGNOSTIC USE; GENETICS; MENTAL HEALTH; MIDDLE AGED; PATHOLOGY; SCINTISCANNING;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEINS E; ATROPHY; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; FEMALE; FLUORODEOXYGLUCOSE F18; HIPPOCAMPUS; HUMANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; POSITRON-EMISSION TOMOGRAPHY; TAU PROTEINS;

EID: 84927175331     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2014.03.006     Document Type: Article

References (21)

1. M.S. Albert, S.T. DeKosky, D. Dickson, B. Dubois, H.H. Feldman, and N.C. Fox The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 270 279
2. G.M. McKhann, D.S. Knopman, H. Chertkow, BT Hyman, CR Jr Jack, and CH Kawas The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 263 269
3. C.R. Jack Jr., D.S. Knopman, W.J. Jagust, L.M. Shaw, P.S. Aisen, and M.W. Weiner Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade Lancet Neurol 9 2010 119 128
4. C.R. Jack Jr., D.S. Knopman, S.D. Weigand, H.J. Wiste, P. Vemuri, and V. Lowe An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease Ann Neurol 71 2012 765 775
5. A.M. Fagan, M.A. Mintun, R.H. Mach, SY Lee, CS Dence, and AR Shah Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans Ann Neurol 59 2006 512 519
6. W.J. Jagust, S.M. Landau, L.M. Shaw, J.Q. Trojanowski, R.A. Koeppe, and E.M. Reiman Relationships between biomarkers in aging and dementia Neurology 73 2009 1193 1199
7. SM Landau, M Lu, AD Joshi, M Pontecorvo, and MA Mintun Trojanowski JQ, et al. Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid Ann Neurol 74 2013 826 836
8. I. Yakushev, M.J. Muller, H.G. Buchholz, U. Lang, H. Rossmann, and H. Hampel Stage-dependent agreement between cerebrospinal fluid proteins and FDG-PET findings in Alzheimer's disease Curr Alzheimer Res 9 2012 241 247
9. V.J. Lowe, P.J. Peller, S.D. Weigand, C. Montoya Quintero, N. Tosakulwong, and P. Vemuri Application of the National Institute on Aging-Alzheimer's Association AD criteria to ADNI Neurology 80 2013 2130 2137
10. G.B. Frisoni, M. Bocchetta, G. Chetelat, G.D. Rabinovici, M.J. de Leon, and J. Kaye Imaging markers for Alzheimer disease: which vs how Neurology 81 2013 487 500
11. N.A. Verwey, W.M. van der Flier, K. Blennow, C. Clark, S. Sokolow, and P.P. De Deyn A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease Ann Clin Biochem 46 Pt 3 2009 235 240
12. P.S. Aisen, R.C. Petersen, M.C. Donohue, A. Gamst, R. Raman, and R.G. Thomas Clinical core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans Alzheimers Dement 6 2010 239 246
13. S.M. Landau, M.A. Mintun, A.D. Joshi, R.A. Koeppe, R.C. Petersen, and P.S. Aisen Amyloid deposition, hypometabolism, and longitudinal cognitive decline Ann Neurol 72 2012 578 586
14. W.J. Jagust, D. Bandy, K. Chen, N.L. Foster, S.M. Landau, and C.A. Mathis The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core Alzheimers Dement 6 2010 221 229
15. C.R. Jack Jr., M.A. Bernstein, N.C. Fox, P. Thompson, G. Alexander, and D. Harvey The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods J Magn Reson Imaging 27 2008 685 691
16. S.M. Landau, D. Harvey, C.M. Madison, E.M. Reiman, N.L. Foster, and P.S. Aisen Comparing predictors of conversion and decline in mild cognitive impairment Neurology 75 2010 230 238
17. S. Kim, S. Swaminathan, L. Shen, S.L. Risacher, K. Nho, and T. Foroud Genome-wide association study of CSF biomarkers A{beta}1-42, t-tau, and p-tau181p in the ADNI cohort Neurology 76 2011 69 79
18. L.M. Shaw, H. Vanderstichele, M. Knapik-Czajka, C.M. Clark, P.S. Aisen, and R.C. Petersen Cerebrospinal fluid biomarker signature in Alzheimer's Disease Neuroimaging Initiative subjects Ann Neurol 65 2009 403 413
19. J.L. Fleiss, B. Levin, and M.C. Paik Statistical methods for rates and proportions 2003 John Wiley & Sons, Inc
20. C.R. Jack Jr., D.S. Knopman, W.J. Jagust, R.C. Petersen, M.W. Weiner, and P.S. Aisen Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers Lancet Neurol 12 2013 207 216
21. R.C. Petersen, P. Aisen, B.F. Boeve, Y.E. Geda, R.J. Ivnik, and D.S. Knopman Criteria for mild cognitive impairment due to Alzheimer's disease in the community Ann Neurol 2013 10.1002/ana.23931